Showing results (121-130 of 132) with videos related to
Sort By:
Pageof 14
Nature Medicine|September 14, 2021
Safety, immunogenicity and efficacy of PfSPZ Vaccine against malaria in infants in western Kenya: a double-blind, randomized, placebo-controlled phase 2 trialMartina Oneko, Laura C Steinhardt, Reuben Yego, et al.Plos One|April 1, 2022
Validation of xMAP SARS-CoV-2 Multi-Antigen IgG assay in NigeriaNnaemeka C Iriemenam, Fehintola A Ige, Stacie M Greby, et al.The Lancet. Microbe|June 8, 2026
Evaluation of the effectiveness of artemether-lumefantrine and artesunate-pyronaridine each combined with single low-dose primaquine in adults with Plasmodium falciparum infection in Ethiopia: a phase 2/3, observer-masked, randomised, parallel-group trialMigbaru Keffale Bezabih, Tadesse Misganaw, Legesse Alamerie Ejigu, et al.The Lancet. Infectious Diseases|September 25, 2023
Effect of primaquine dose on the risk of recurrence in patients with uncomplicated Plasmodium vivax: a systematic review and individual patient data meta-analysisRobert J Commons, Megha Rajasekhar, Peta Edler, et al.Plos Medicine|October 5, 2019
The efficacy of dihydroartemisinin-piperaquine and artemether-lumefantrine with and without primaquine on Plasmodium vivax recurrence: A systematic review and individual patient data meta-analysisRobert J Commons, Julie A Simpson, Kamala Thriemer, et al.JCI Insight|April 30, 2024
Innate immune activation restricts priming and protective efficacy of the radiation-attenuated PfSPZ malaria vaccineLeetah Senkpeil, Jyoti Bhardwaj, Morgan R Little, et al.Malaria Journal|October 11, 2023
Effect of adherence to primaquine on the risk of Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysisParinaz Mehdipour, Megha Rajasekhar, Saber Dini, et al.The Lancet. Child & Adolescent Health|September 27, 2024
Primaquine for uncomplicated Plasmodium vivax malaria in children younger than 15 years: a systematic review and individual patient data meta-analysisRobert J Commons, Megha Rajasekhar, Elizabeth N Allen, et al.Plos Medicine|November 19, 2020
The risk of Plasmodium vivax parasitaemia after P. falciparum malaria: An individual patient data meta-analysis from the WorldWide Antimalarial Resistance NetworkMohammad S Hossain, Robert J Commons, Nicholas M Douglas, et al.BMC Medicine|August 2, 2019
The haematological consequences of Plasmodium vivax malaria after chloroquine treatment with and without primaquine: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysisRobert J Commons, Julie A Simpson, Kamala Thriemer, et al.Pageof 14